IBRX ImmunityBio, Inc.

$7.91▲ +2.46% Healthcare Other
After hours $7.92▲ +0.18% Sep 11, 7:54 PM ET
Volume 12.47M Avg Volume (10D) 7.66M
Key Metrics & Fundamentals
Market Cap
$8.38B
P/E Ratio
–
Div Yield
–%
52W Range
1.95 - 12.43
% vs 50 MA
1.21%
% vs 200 MA
17.76%
RSI-14
50.3
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.62
Free Cash Flow
-$70.03M
Gross Rev
$51.24M
Gross Profit
$50.94M
EBITDA
-$149.86M
COGS
$298,000
Operating Exp
$112.64M
Operating Income
-$61.70M
EBIT
-$61.70M
Pretax Income
-$230.39M
Net Income
-$230.38M
EPS (Diluted)
-0.22
Price & Volume History
Loading chart…
Recent News
IBRX Stock Eyes Worst Week Since July: New Patent Eyes Broader Anktiva Use Ahead Of Lung Cancer Conference
Stocktwits · Sep 11, 2026 8:04 AM
SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts
Stocktwits · Sep 10, 2026 3:03 AM
Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report?
Zacks · Sep 3, 2026 3:30 PM
SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’
Stocktwits · Sep 1, 2026 6:09 AM
IBRX Stock Heads For Best Week In Over 2 Months After Chairman Soon Shiong’s Cancer Vaccine Trial Milestone Update
Stocktwits · Aug 27, 2026 5:57 PM
SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future
Stocktwits · Aug 27, 2026 7:09 AM
SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon
Stocktwits · Aug 26, 2026 8:12 AM
SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology
Stocktwits · Aug 21, 2026 2:46 AM
Goldman Sachs Builds $75M Bet Across CAPR, SLS And IBRX As Major Catalysts Loom
Stocktwits · Aug 17, 2026 5:17 AM
SLS And IBRX Eye Green Weekly Close: Vanguard’s Major Stakes In Cancer Drugmakers Steal The Spotlight
Stocktwits · Aug 14, 2026 2:24 AM
Financial Overview - Income Statement Quarterly

See IBRX's money flow as a full page

Social Sentiment
Avg +0.76 · 76 posts
DiscussionNewsCurious If Anyone Has Thoughts on IBRX (ImmunityBio)
r/stocks · Aug 7, 2026
The author expresses a positive long-term view and highlights FDA approval and international expansion.
positive +0.60
DDNewsTrade(IBRX) another banger after my last banger call
r/stocks · Jul 30, 2026
The author highlights recent approvals and ongoing trials, expressing excitement about the potential investment. The term 'banger' also indicates strong bullish sentiment.
very_positive +0.80
DDNewsDiscussion$IBRX — real holder using AI for clarity, not hype. Here's why I think the fundamentals justify the run
r/wallstreetbets · Jul 9, 2026
The author highlights positive revenue growth and regulatory approvals for IBRX, expressing a long position and confidence in the fundamentals.
very_positive +1.00
DDNewsTradeMemeTrump might cure cancer and IBRX could moon with or without the short squeeze.
r/wallstreetbets · May 11, 2026
High anticipation of a price increase driven by speculative factors and a key figure's involvement.
very_positive +0.80
DDNewsDiscussion$IBRX DD: the class action headline looks scarier than the actual facts
r/wallstreetbets · Apr 17, 2026
The post highlights a lawsuit and concerns about misleading claims, creating a negative sentiment.
negative +0.60
Page 1 of 16 (76 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙